Remission has become in the last few years an accessible objective in the management of rheumatoid arthritis (RA) patients due to treatment improvement and the development of international guidelines. The aim of rheumatoid arthritis treatment is to achieve remission and to stop the progression of structural damage. Different definitions of remission exist. Most of them take into account clinical and biological features and refer to low clinical and biological inflammation states (DAS28, DAS, SDAI, CDAI, ACR/EULAR remission criteria ...).
Several studies have shown that patients in clinical remission or low disease activity (LDA) state may show structural progression on radiography. More sensitive tools than clinical examination and radiography are needed to identify RA patients in clinical remission or LDA state at risk of structural progression in order to adapt treatment. MRI, which has a high sensitivity for detecting inflammation and erosion, could be useful in this respect.
Disclosure of Interest None Declared